Hepatitis C Information Central


Discover the latest news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information

News, Updates and Commentary

Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

77 More Hepatitis Cases Linked to Clinic
Seventy-seven more people that were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said. Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist with the

Officials: 77 more hepatitis cases may trace to clinic
AM ET LAS VEGAS (AP) - Health officials in Las Vegas say 77 more people who were treated at an outpatient clinic have been diagnosed with hepatitis C. Authorities can't say for sure how the 77 people were infected. Officials say they know each was

More hepatitis cases may trace to clinic
AM CDT LAS VEGAS - Seventy-seven more people have been diagnosed with hepatitis C that they may have contracted during treatment at a Las Vegas outpatient clinic, public health administrators said Thursday.The 77 people are among about 400 former


UPDATES AND COMMENTARY RSS Feed

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...

Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...

Hepatitis C Complications Helped by Maintenance Interferon
A four-year study confirms that low-dosage maintenance interferon therapy prevents disease progression in those with portal hypertension or cirrhosis from Hepatitis C....

International Conference Reporter from

11th World Congress of Gastroenterology (WCOG)

Vienna, Austria

September 10, 1998

Liver biopsy in chronic hepatitis – why do it?

Dr P Scheuer, London, UK, provided strong arguments for the continued use of liver biopsy in diagnosis, pre- and post-treatment assessment, follow up, and research, in chronic hepatitis.

Biopsy adds much to liver function tests in diagnosis, and is essential for total assessment. Although HCV RNA in serum is now often used for diagnosis of Hepatitis C, biopsy can give more insight into the nature of disease, showing extent of inflammation and cirrhosis. Biopsy can also illustrate which disease is responsible for liver damage in cases of e.g. hepatitis plus thalassaemia.

In assessing patients’ need for treatment, biopsy is also useful. Originally, pathologists had difficulty in classifying hepatitis by histology alone, but a number of grading and staging systems have been used over the years. Clinicians require a numerical evaluation to assist their decisions to treat, and the simple algorithm of the METAVIR group has been very useful. This has a range of 0-3, and does not detect minor histological changes. On the other hand, the Knodell updated scoring allows a cumulative grading of 0-18, and a staging of 0-6. However, a ‘grading total’ figure should not be used to assume the need for therapy, since these numbers are not true measurements, but a hierarchy of gradings.

Although largely unnecessary for detecting cirrhosis nowadays, biopsy is still often used to do so. Pathology is also useful in identifying hepatocellular carcinoma when there is not obvious tumour mass, and negative serum alpha-fetoprotein.

Liver tissue is essential to cell-based research studies, such as analysis of cytotoxic lymphocytes in a diseased organ. Various in situ staining techniques obviously need tissue sections to be useful. As a concluding note, Dr Scheuer referred to a study which had shown that progression of fibrosis is related to age of the patient at infection, duration of disease, high alcohol intake, and male sex – purely derived by a sophisticated scoring system of biopsy pathology.

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 09 May 2008